Hitting a Nerve

Here’s what you need to know about the newest technology approved for dry eye disease therapy.

Plug into Dry Eye Therapy

Don’t overlook the benefits of punctal occlusion for your DED patients. New technologies have made it better than ever.

Tales From TFOS

Ocular surface experts from around the world recently came together to share groundbreaking research.

When the Pain Won’t Go Away

Early diagnosis is key to helping patients overcome ocular neuropathic pain associated with dry eye disease.

Say Hii to Xiidra

The first new DED drug in more than 13 years is finally here. How does it work and what are the potential implications for optometry?

Mind Games

How optometrists can help dry eye patients who experience symptoms without signs.

The Diagnosis Doesn’t Add Up

When signs and symptoms of dry eye disease don’t correlate, clinicians must use everything in their toolboxes to determine the correct management strategy.

The Dry Eye Deluge

Last year saw an explosion of advancements in the world of ocular surface disease—and we are finding more every day.

Too Many Tears: Is it Dry Eye?

Patients with a number of underlying conditions experience epiphora. How do you diagnose, educate and treat these patients?

A Grain of Salt?

Skeptics wonder if osmolarity testing lacks clinical value. Here’s why they’re wrong.

November 3-5, 2017

December 1-2, 2017

December 15-16, 2017